North America Lyophilized Injectable Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)

No. of Pages: 126    |    Report Code: BMIRE00027594    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Lyophilized Injectable Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Lyophilized Injectable Market – By Type of Packaging

1.3.2        North America Lyophilized Injectable Market – By Type of Delivery

1.3.3        North America Lyophilized Injectable Market – By Indication

1.3.4        North America Lyophilized Injectable Market – By End User

1.3.5        North America Lyophilized Injectable Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Lyophilized Injectable Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Lyophilized Injectable Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Demand for Contract Research Manufacturing Services

5.1.2        Increasing Demand of Biologics

5.2         Market Restraints

5.2.1        Product Recalls

5.3         Market Opportunities

5.3.1        Expansion of Pipeline of Lyophilized Injectable Drugs

5.4         Future Trends

5.4.1        Advancement in Lyophilized Packaging

5.5         Impact Analysis

6.           Lyophilized Injectable Market– North America Analysis

6.1         North America Lyophilized Injectable Market Revenue Forecast and Analysis

7.           North America Lyophilized Injectable Market Analysis – By Type of Packaging

7.1         Overview

7.2         North America Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

7.3         Single-use vials

7.3.1        Overview

7.3.2        Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Point-of-Care Reconstitution

7.4.1        Overview

7.4.2        Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028  (US$ Million)

7.5         Specialty Packaging

7.5.1        Overview

7.5.2        Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Lyophilized Injectable Market Analysis – By Type of Delivery

8.1         Overview

8.2         North America Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

8.3         Prefilled Diluent Syringes

8.3.1        Overview

8.3.2        Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Single Step Devices

8.4.1        Overview

8.4.2        Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Proprietary Reconstitution Devices

8.5.1        Overview

8.5.2        Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Multi-Step Devices

8.6.1        Overview

8.6.2        Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Lyophilized Injectable Market Analysis – By Indication

9.1         Overview

9.2         North America Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

9.3         Metabolic and Oncology Conditions

9.3.1        Overview

9.3.2        Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Autoimmune Diseases

9.5.1        Overview

9.5.2        Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Indications

9.6.1        Overview

9.6.2        Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Lyophilized Injectable Market Analysis – By End User

10.1      Overview

10.2      North America Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028  (US$ Million)

10.5      Specialty Clinics

10.5.1     Overview

10.5.2     Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Other End Users

10.6.1     Overview

10.6.2     Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Lyophilized Injectable Market – Country Analysis

11.1      Overview

11.1.1     North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.1.1.1       US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       US: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.1.1.4       US: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.1.1.5       US: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.1.1.6       US: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.1.1.2       Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Canada: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.1.2.4       Canada: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.1.2.5       Canada: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.1.2.6       Canada: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

11.1.1.3       Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)

11.1.1.3.4       Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)

11.1.1.3.5       Mexico: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)

11.1.1.3.6       Mexico: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Baxter

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nipro

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Curia Global, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Recipharm AB

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Vetter Pharma

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Jubilant HollisterStier (Jubilant Pharma Limited)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Aristopharma Ltd.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      CordenPharma International

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Credence MedSystems, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   S.G. Biopharm Pvt. Ltd.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             North America Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Recent Inorganic Growth Strategies

Table 15.          Recent Organic Growth Strategies

Table 16.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           North America Lyophilized Injectable Market Segmentation

Figure 2.           North America Lyophilized Injectable Market – By Country

Figure 3.           North America Lyophilized Injectable Market Overview

Figure 4.           North America Lyophilized Injectable Market, By Type of Packaging

Figure 5.           North America Lyophilized Injectable Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Lyophilized Injectable Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Lyophilized Injectable Market– Revenue Forecast and Analysis

Figure 10.        North America Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

Figure 11.        North America Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

Figure 15.        North America Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

Figure 20.        orth America Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

Figure 25.        North America Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        North America Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        North America: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30.        North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

Figure 31.        US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.          Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - North America Lyophilized Injectable Market

  1. Aristopharma Ltd.
  2. Baxter
  3. CordenPharma International
  4. Credence MedSystems, Inc.
  5. Curia Global, Inc.
  6. Jubilant HollisterStier (Jubilant Pharma Limited)
  7. Nipro
  8. Recipharm AB
  9. S.G. Biopharm Pvt. Ltd.
  10. Vetter Pharma